Genomics|Genetic Testing|Guidelines: Pharmacogenomics

Genomics|Genetic Testing|Guidelines

Pharmacogenomics

Guideline	Organization	Published
HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions	Canadian Pharmacogenomics Network for Drug Safety Clinical Recommendation Group	2014
CYP2C9 and HLA-B genotypes and phenytoin dosing	Clinical Pharmacogenetics Implementation Consortium	2014
Cytochrome P450 2D6 genotype and codeine therapy - 2014 update	Clinical Pharmacogenetics Implementation Consortium	2014
HLA-B Genotype and Abacavir Dosing - 2014 update	Clinical Pharmacogenetics Implementation Consortium	2014
IFNL3 (IL28B) genotype and PEG interferon-α-based regimens	Clinical Pharmacogenetics Implementation Consortium	2014
Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process	Clinical Pharmacogenetics Implementation Consortium	2014
Ivacaftor therapy in the context of CFTR genotype	Clinical Pharmacogenetics Implementation Consortium	2014
Rasburicase therapy in the context of G6PD deficiency genotype	Clinical Pharmacogenetics Implementation Consortium	2014
SLCO1B1 and simvastatin-induced myopathy - 2014 update	Clinical Pharmacogenetics Implementation Consortium	2014
Testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation	Australian expert panel	2013
CYP2D6 genotyping for safe and efficacious codeine therapy	Canadian Pharmacogenomics Network for Drug Safety Clinical Recommendation Group	2013
CYP2C19 genotype and clopidogrel therapy - 2013 update	Clinical Pharmacogenetics Implementation Consortium	2013
CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants	Clinical Pharmacogenetics Implementation Consortium	2013
Dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing	Clinical Pharmacogenetics Implementation Consortium	2013
HLA-B genotype and carbamazepine dosing	Clinical Pharmacogenetics Implementation Consortium	2013
Human leukocyte antigen-B genotype and allopurinol dosing	Clinical Pharmacogenetics Implementation Consortium	2013
Thiopurine methyltransferase genotype and thiopurine dosing - 2013 update	Clinical Pharmacogenetics Implementation Consortium	2013
SLCO1B1 and simvastatin-induced myopathy	Clinical Pharmacogenetics Implementation Consortium	2012
Testing for cytochrome P450 polymorphisms in adults with nonpsychotic depression treated with selective serotonin reuptake inhibitors	Evaluation of Genomic Applications in Practice and Prevention	2007